Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Reports 94-Percent Increase in Fiscal Q1 Revenues, Though Profit Swings to Loss

NEW YORK (GenomeWeb News) – Clinical Data yesterday reported a 94-percent revenue increase for its fical first quarter of 2007 as last year's profit swung to a loss.
 
The company reported $24.8 million in revenues for the quarter ended June 30, up from $12.8 million during the same quarter a year ago.
 
Product revenue climbed 26 percent to $14 million, from $11.3 million in the prior year. Service revenue surged to $10.6 million from $1.5 million in the prior year.
 
Clinical Data’s R&D expenses for the quarter climbed to $3.2 million from $707,000 during the same period a year ago.
 
The company’s net income for the quarter swung to a loss of $6.2 million, compared to a profit of $407,000 in the year-ago period.
 
As of June 30, Clinical Data had $19 million in cash and cash equivalents.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.